Think

Search This Blog

These Patients Got the Cure. Then It Went Away.

September 22, 2025

Get link
Facebook
X
Pinterest
Email
Other Apps

Gene therapies for rare diseases are frequently developed then discarded by drug companies because they can’t afford to produce the treatment for more patients.

Gina Kolata | NYTimes Health | Disclosure

Get link
Facebook
X
Pinterest
Email
Other Apps

Comments

Female Cardiothoracic Surgeons, Unlocking the Male Fortress

Less than 10 percent of heart and lung surgeons in the United States are women. At a recent conference, they vowed to change that. Elisabeth Bumiller and Alyssa Schukar | NYTimes Health | Disclosure

Wheelchair? Hearing Aids? Yes. ‘Disabled’? No Way.

Many older Americans shun an identity that could bring helpful accommodations, improve care and provide community. Paula Span | NYTimes Health | Disclosure

New Gene-Editing Strategy Could Help Development of Treatments for Rare Diseases

Instead of requiring personalized gene edits for each patient, the new approach could create a standardized method to use for many diseases. Pam Belluck and Carl Zimmer | NYTimes Health | Disclosure

F.D.A. Will Remove Black Box Warnings From Hormone Treatments for Menopause

The benefits of hormone replacement have been underappreciated, Dr. Marty Makary, the agency’s commissioner, said on Monday. Critics described evidence for the change as insufficient. Roni Caryn Rabin | NYTimes Health | Disclosure

She’s on a Mission to Make the World More Bike-Friendly

Melissa Bruntlett advocates equitable, inclusive and sustainable mobility — and writes about other women who do, too. Tanya Mohn | NYTimes Health | Disclosure

These Patients Got the Cure. Then It Went Away.

Gene therapies for rare diseases are frequently developed then discarded by drug companies because they can’t afford to produce the treatment for more patients.

Comments

Post a Comment